Aroa Biosurgery (ASX:ARX) Equity-to-Asset : 0.86 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Aroa Biosurgery's Total Stockholders Equity for the quarter that ended in Sep. 2023 was A$90.25 Mil. Aroa Biosurgery's Total Assets for the quarter that ended in Sep. 2023 was A$104.59 Mil. Therefore, Aroa Biosurgery's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.86.

The historical rank and industry rank for Aroa Biosurgery's Equity-to-Asset or its related term are showing as below:

ASX:ARX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.73 Med: 0.87 Max: 0.9
Current: 0.86

During the past 4 years, the highest Equity to Asset Ratio of Aroa Biosurgery was 0.90. The lowest was 0.73. And the median was 0.87.

ASX:ARX's Equity-to-Asset is ranked better than
84.25% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: 0.65 vs ASX:ARX: 0.86

Aroa Biosurgery Equity-to-Asset Historical Data

The historical data trend for Aroa Biosurgery's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Equity-to-Asset Chart

Aroa Biosurgery Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Equity-to-Asset

0.76

0.73

0.89

0.87

Aroa Biosurgery Semi-Annual Data
	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Equity-to-Asset	Get a 7-Day Free Trial			0.90	0.89	0.88	0.87	0.86

Competitive Comparison of Aroa Biosurgery's Equity-to-Asset

For the Medical Devices subindustry, Aroa Biosurgery's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aroa Biosurgery's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Aroa Biosurgery's Equity-to-Asset falls into.

Aroa Biosurgery Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Aroa Biosurgery's Equity to Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Equity to Asset (A: Mar. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	95.377	/	109.071
	=	0.87

Aroa Biosurgery's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	90.252	/	104.592
	=	0.86

Aroa Biosurgery (ASX:ARX) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Aroa Biosurgery Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Aroa Biosurgery (ASX:ARX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Equity-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022

Website

https://www.aroabio.com

Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines